2/20
08:28 am
lung
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
Medium
Report
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
2/20
08:26 am
lung
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 [Yahoo! Finance]
Medium
Report
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 [Yahoo! Finance]
2/20
08:00 am
lung
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
Medium
Report
Pulmonx to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
1/10
07:02 pm
lung
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return [Yahoo! Finance]
Low
Report
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return [Yahoo! Finance]
12/25
07:00 pm
lung
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story [Yahoo! Finance]
Low
Report
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story [Yahoo! Finance]
12/11
02:33 am
lung
What New Catalysts Are Shifting the Pulmonx Story for Investors [Yahoo! Finance]
Medium
Report
What New Catalysts Are Shifting the Pulmonx Story for Investors [Yahoo! Finance]
12/3
04:05 pm
lung
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
High
Report
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)